» Articles » PMID: 38067435

Integrative Analysis of Machine Learning and Molecule Docking Simulations for Ischemic Stroke Diagnosis and Therapy

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2023 Dec 9
PMID 38067435
Authors
Affiliations
Soon will be listed here.
Abstract

Due to the narrow therapeutic window and high mortality of ischemic stroke, it is of great significance to investigate its diagnosis and therapy. We employed weighted gene coexpression network analysis (WGCNA) to ascertain gene modules related to stroke and used the maSigPro R package to seek the time-dependent genes in the progression of stroke. Three machine learning algorithms were further employed to identify the feature genes of stroke. A nomogram model was built and applied to evaluate the stroke patients. We analyzed single-cell RNA sequencing (scRNA-seq) data to discern microglia subclusters in ischemic stroke. The RNA velocity, pseudo time, and gene set enrichment analysis (GSEA) were performed to investigate the relationship of microglia subclusters. Connectivity map (CMap) analysis and molecule docking were used to screen a therapeutic agent for stroke. A nomogram model based on the feature genes showed a clinical net benefit and enabled an accurate evaluation of stroke patients. The RNA velocity and pseudo time analysis showed that microglia subcluster 0 would develop toward subcluster 2 within 24 h from stroke onset. The GSEA showed that the function of microglia subcluster 0 was opposite to that of subcluster 2. AZ_628, which screened from CMap analysis, was found to have lower binding energy with Mmp12, Lgals3, Fam20c, Capg, Pkm2, Sdc4, and Itga5 in microglia subcluster 2 and maybe a therapeutic agent for the poor development of microglia subcluster 2 after stroke. Our study presents a nomogram model for stroke diagnosis and provides a potential molecule agent for stroke therapy.

Citing Articles

Unveiling the anxiolytic and analgesic effects of citronellal in Swiss mice: in vivo and in silico insights into COX and GABAA receptor pathways.

Islam M, Al Hasan M, Chowdhury R, Mia E, Rakib I, Yana N Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39607546 DOI: 10.1007/s00210-024-03665-9.


Machine learning-driven discovery of novel therapeutic targets in diabetic foot ulcers.

Yu X, Wu Z, Zhang N Mol Med. 2024; 30(1):215.

PMID: 39543487 PMC: 11562697. DOI: 10.1186/s10020-024-00955-z.

References
1.
Cai Y, Guo H, Fan Z, Zhang X, Wu D, Tang W . Glycogenolysis Is Crucial for Astrocytic Glycogen Accumulation and Brain Damage after Reperfusion in Ischemic Stroke. iScience. 2020; 23(5):101136. PMC: 7240195. DOI: 10.1016/j.isci.2020.101136. View

2.
Pinzi L, Rastelli G . Molecular Docking: Shifting Paradigms in Drug Discovery. Int J Mol Sci. 2019; 20(18). PMC: 6769923. DOI: 10.3390/ijms20184331. View

3.
Spitzer D, Guerit S, Puetz T, Khel M, Armbrust M, Dunst M . Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood-brain barrier in acute ischemic stroke. Acta Neuropathol. 2022; 144(2):305-337. PMC: 9288377. DOI: 10.1007/s00401-022-02452-1. View

4.
Benakis C, Simats A, Tritschler S, Heindl S, Besson-Girard S, Llovera G . T cells modulate the microglial response to brain ischemia. Elife. 2022; 11. PMC: 9747154. DOI: 10.7554/eLife.82031. View

5.
Kim J, Kim S, Kim B, Lee S, Cha S, Lee D . Prospects of Therapeutic Target and Directions for Ischemic Stroke. Pharmaceuticals (Basel). 2021; 14(4). PMC: 8065883. DOI: 10.3390/ph14040321. View